Back to
RENAISSANCE TECHNOLOGIES LLC
NBIX28 quarters
Position history for
RENAISSANCE TECHNOLOGIES LLC's holdings in NEUROCRINE BIOSCIENCES INC
Yes. Renaissance Technologies holds 2,335,897 shares of NBIX (Neurocrine Biosciences), worth $393.7M, as of its Q2 2026 13F filing. It reduced the position by 83,000 shares (-3.4%) from Q1 2026. Renaissance Technologies has held NBIX in every 13F on record since Q3 2019, 28 quarterly filings. NBIX is 0.5% of Renaissance Technologies' reported 13F portfolio.
Current Value
$393.7M
Current Shares
2.3M
Total Value Change
+$393.3M
Total Shares Change
+2.3M
Quarter-by-Quarter History
Other major holders of NBIX: BlackRock, Inc., BlackRock Finance, Inc.